HSB Trustee Company Private Limited (On behalf of Hari Shanker Bhartia Family Trust) and HS Trustee Company Private Limited (On behalf of Hari Shanker Bhartia Family Trust) has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Hari Shanker Bhartia Family Trust, acting as promoter of Jubilant Pharmova Limited, has filed a mandatory annual declaration under SEBI's Takeover Regulations. The declaration states that the promoters and persons acting in concert have not created any encumbrance (such as pledge or lien) on the company's shares during the financial year ended March 31, 2025. This is a routine annual compliance filing required under Regulation 31(4) and was signed by Aashti Bhartia, Director of the trustee companies.
This is a routine regulatory disclosure and is neutral for shareholders. It simply confirms that the promoter group did not pledge or otherwise encumber their shareholding during the year, which is mildly reassuring regarding promoter financial health.